[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100517297":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":18,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":18,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":18,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":18,"overallStatus":40,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Ajou University School of Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Maxigesic group","EXPERIMENTAL","Administration of Maxigesic before surgery start.",[13],"Drug: Maxigesic administration",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","Administration of normal saline before surgery start.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Maxigesic administration","Preoperative Maxigesic IV administration",[9],[26],"Preoperative Maxigesic administration",[28],{"name":29,"affiliation":5,"role":30},"In Kyong Yi, MD","PRINCIPAL_INVESTIGATOR",[32],{"name":29,"role":33,"phone":34,"phoneExt":35,"email":36},"CONTACT","+82-31-219-5579","7724","lyrin01@gmail.com",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":18,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Ajou university school of medicine","RECRUITING","Suwon","Gyeonggi-do","16499","South Korea",{"type":46,"coordinates":47},"Point",[48,49],127.00889,37.29111,{"lat":49,"lon":48},[52],{"name":29,"role":33,"phone":34,"phoneExt":35,"email":36},{"type":30,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"In-kyong Yi","Assitant professor","100517297","the-effect-of-preoperative-maxigesic-on-intraoperative-remifentanil-requirement-100517297",false,"NCT06015711","The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement","The Effect of Preoperative Maxigesic® Administration on Analgesic Nociception Index (ANI) Guided Remifentanil Administration","Inclusion Criteria:\n\n* Adult patients (19-60 years old) with ASA physical status 1, 2, 3\n* Scheduled surgery under general anesthesia\n\nExclusion Criteria:\n\n* The patient does not conset\n* Pregnancy\n* hepatic disorder\n* Renal disorder\n* Asthma\n* Hypersensitivity to the NSAIDs or acetaminophen\n* Patients receiving chronic pain therapy\n* Drug dependence\n* Patients taking psychiatric drugs\n* Alcoholics\n* History of gastrointestinal ulcer or bleeding","ALL","19 Years","60 Years",{"count":67,"type":68},96,"ESTIMATED","INTERVENTIONAL",[71],"NA","Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.",[74],"Opioid Use","2025-09-30",{"date":77,"type":78},"2025-10-03","ACTUAL",{"date":80,"type":78},"2023-08-30",{"date":82,"type":68},"2026-12-31",{"name":5,"class":6},1]